Hematology analyzers are used to perform different types of coagulation tests. These are computerized, automated and highly specialized machines that count the number of cells from the blood samples. The result of this counting is better known as complete blood count or CBC. Different types of analyzers are used for different types of results. Global rise in demand is considered to be the strongest driver for the hematology analyzers market. Highly sensitive point of care testing is also considered to be a strong driver for the global industry. According to the experts, technological advancements are also expected to play key role in the overall development of the global market, which is a great sign for the current players as well as interested investors.
Segmentation in Hematology Analyzers Industry
Researchers segment the global hematology analyzers market on the basis of the different types of products and services. They also analyze other crucial segments of the market, which include the end-users and demand patterns across different geographic verticals. On the basis of the types of products, the hematology analyzers market is divided into various instruments and reagents. Major end-user segments of the industry include clinical testing laboratories, research institutes including academic and public and private research institutes, commercial organizations and stand-alone hospitals and institutes. On the basis of geographic regions, the global market is segmented into North America, Latin America, Middle East and Africa, Asia Pacific and the rest of the world.
Trends and Drivers
The global hematology analyzers market is driven by the five major driving factors. These factors include development of the high throughput analyzers, demand for the basic flow cytometry techniques, development of high sensitivity point-of-care testing, rising adoption of automated instruments and constant technological advancements. Introduction of digital imaging systems in the hematology laboratories, growth in demand across emerging markets like India, Brazil, and China and such other regions and strong use of microfluidics technology are expected to create strong business opportunities for the global market. However, product recalls, slow rate of adoption and high cost of the analyzers are expected to be strong restraining factors for the market.
According to the analysis of the global trends, driving factors, restraints and geographic analysis, the researchers expect stability for the market. As per the latest reports, the global hematology analyzers market is expected to grow at a steady CAGR of 4.5% from 2014 to reach past $3.13 billion by the end of the year 2019. During the forecasting period, North America is expected to maintain strong growth. Asia Pacific region on the other hand is also expected to witness healthy growth in terms of overall adoption and CAGR.